BridgeMD
New treatment option for Aortic Stenosis
Official title Reversibility of Cardiac Conduction Disturbances Following TAVI
ClinicalTrials.gov ID: NCT06481137
What this study is testing
- What it's testing
- The management of patients with conduction disturbances (CDs) after transcatheter aortic valve implantation (TAVI) is unclear, especially in those with de novo electrocardiographic CDs (ECG-CDs) such as left bundle branch block. In this study, the investigators will evaluate the incidence of retrogradation of infra-Hisian CDs in patients with de novo ECG-CDs and positive electrophysiological study (EPS) 3-7 days following TAVI.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patients with indication for electrophysiological (EP) study after TAVI implantation according to European Guidelines. Patients must have persistent...
- De novo LBBB with QRS complex \>150ms and/or PR interval ≥240ms.
- QRS widening or post-procedural PR lengthening \> 20ms in patients with baseline ECG-CDs.
You likely can't join if
- Patients with previous pacemaker or implantable defibrillator.
- Patients with baseline complete right bundle branch block.
- Patients in need of cardiac resynchronization or physiological stimulation following TAVI.
- Valve-in-valve procedures.
- TAVI procedures in patients with severe aortic insufficiency.
- Inability to sign the informed consent form.
The study team makes the final eligibility decision.
Where it's taking place
- L'Hospitalet de Llobregat, Barcelona, Spain
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include L'Hospitalet de Llobregat, Barcelona, Spain. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.